3-iodobenzylguanidine has been researched along with aldosterone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzon, L; Boscaro, M; Fallo, F; Gregianin, M; Macrì, C; Scaroni, C; Sonino, N | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Nakata, T; Sumino, H; Toyama, T | 1 |
1 trial(s) available for 3-iodobenzylguanidine and aldosterone
| Article | Year |
|---|---|
Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Radiopharmaceuticals; Spironolactone; Stroke Volume; Sympathetic Nervous System | 2002 |
3 other study(ies) available for 3-iodobenzylguanidine and aldosterone
| Article | Year |
|---|---|
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Topics: 17-alpha-Hydroxyprogesterone; 3-Iodobenzylguanidine; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Biopsy, Needle; Dehydroepiandrosterone Sulfate; Dexamethasone; Diagnosis, Differential; Female; Hormones; Humans; Hydrocortisone; Hyperaldosteronism; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Postmenopause; Premenopause; Radiopharmaceuticals; Renin; Retrospective Studies; Selenium Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.
Topics: 3-Iodobenzylguanidine; Administration, Intravenous; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Organ Size; Radionuclide Imaging; Sympathetic Nervous System | 2014 |